Global disparities in SARS-CoV-2 genomic surveillance

Anderson F Brito, Elizaveta Semenova, Gytis Dudas, Gabriel W Hassler, Chaney C Kalinich, Moritz U G Kraemer, Joses Ho, Houriiyah Tegally, George Githinji, Charles N Agoti, Lucy E Matkin, Charles Whittaker, Benjamin P Howden, Vitali Sintchenko, Neta S Zuckerman, Orna Mor, Heather M Blankenship, Tulio de Oliveira, Raymond T P Lin, Marilda Mendonça SiqueiraPaola Cristina Resende, Ana Tereza R Vasconcelos, Fernando R Spilki, Renato Santana Aguiar, Ivailo Alexiev, Ivan N Ivanov, Ivva Philipova, Christine V F Carrington, Nikita S D Sahadeo, Céline Gurry, Sebastian Maurer-Stroh, Dhamari Naidoo, Karin J von Eije, Mark D Perkins, Maria van Kerkhove, Sarah C Hill, Ester C Sabino, Oliver G Pybus, Christopher Dye, Samir Bhatt, Seth Flaxman, Marc A Suchard, Nathan D Grubaugh, Guy Baele, Nuno R Faria, Danish Covid-19 Genome Consortium

Publikation: Working paperPreprint

21 Downloads (Pure)

Abstract

Genomic sequencing provides critical information to track the evolution and spread of SARS-CoV-2, optimize molecular tests, treatments and vaccines, and guide public health responses. To investigate the spatiotemporal heterogeneity in the global SARS-CoV-2 genomic surveillance, we estimated the impact of sequencing intensity and turnaround times (TAT) on variant detection in 167 countries. Most countries submit genomes >21 days after sample collection, and 77% of low and middle income countries sequenced <0.5% of their cases. We found that sequencing at least 0.5% of the cases, with a TAT <21 days, could be a benchmark for SARS-CoV-2 genomic surveillance efforts. Socioeconomic inequalities substantially impact our ability to quickly detect SARS-CoV-2 variants, and undermine the global pandemic preparedness.

OriginalsprogEngelsk
DOI
StatusUdgivet - 2022
NavnmedRxiv

Citationsformater